Berkshire Hathaway's Portfolio Now 60% Concentrated in Nine Core Holdings Under Greg Abel

Why It Matters

The re‑allocation of Berkshire’s equity portfolio under Greg Abel reshapes the benchmark for large‑cap value investing. By concentrating 60% of a $320 billion portfolio in nine core holdings, Berkshire amplifies the influence of a handful of stocks on its overall performance, making the conglomerate’s fortunes more tightly linked to the health of those companies. This shift also revives the debate over portfolio diversification versus concentration among institutional investors, especially given the scale of Berkshire’s cash reserves and its ability to move markets through share repurchases. For millions of retail shareholders, the move could mean higher returns if the core names outperform, but also heightened volatility if any of those names face sector‑specific challenges. Moreover, Abel’s early actions—re‑starting buybacks, completing the OxyChem acquisition, and taking a stake in Tokio Marine—signal a proactive approach to capital allocation that contrasts with Buffett’s more passive stance in recent years. The strategy may set a precedent for other conglomerates with large cash piles, encouraging them to adopt a more focused equity strategy rather than spreading capital thinly across a broad array of holdings. As the market watches Berkshire’s performance under this new concentration, it will provide a real‑time case study on the trade‑offs between concentration risk and the potential for outsized gains.

Key Takeaways

• Berkshire Hathaway’s $320 billion marketable equity portfolio is now 60% concentrated in nine core holdings.
• Apple remains the largest position at 18.5% of the portfolio, followed by American Express (15%) and Coca‑Cola (9.8%).
• Greg Abel re‑activated a share‑repurchase program with a $226 million buyback of Berkshire stock in March 2026.
• Recent strategic deals include a $9.7 billion OxyChem acquisition and a $1.8 billion stake in Tokio Marine.
• Berkshire’s Class B shares trade near a 1.4‑times price‑to‑book ratio, lower than the 1.5‑plus levels of prior years.

Pulse Analysis

Greg Abel’s decision to concentrate Berkshire’s equity portfolio reflects a broader industry trend where mega‑cap investors are moving away from ultra‑diversified holdings toward high‑conviction, cash‑generating assets. The move leverages Berkshire’s massive cash hoard—over $100 billion in Treasury bills—to double‑down on a curated set of businesses that have demonstrated resilient cash flows and pricing power. Historically, Berkshire’s diversification was a hedge against the cyclical nature of its operating subsidiaries; today, the sheer scale of its cash reserves reduces the need for such a defensive spread, allowing Abel to pursue a more aggressive, value‑centric stance.

From a market‑structure perspective, the concentration could amplify Berkshire’s impact on the price dynamics of its core stocks. A sizable purchase or sale in Apple, for instance, would ripple through the broader tech sector, given Berkshire’s reputation as a long‑term anchor investor. This influence may also attract activist investors who see Berkshire’s cash as a lever for corporate governance changes in its core holdings. However, the flip side is heightened exposure to sector‑specific risks—any regulatory or demand shock to Apple, AmEx, or Coca‑Cola could disproportionately affect Berkshire’s net asset value, a risk that traditional diversified conglomerates typically avoid.

Looking forward, Abel’s playbook appears to blend Buffett’s disciplined capital allocation with a modern, data‑driven focus on concentration. The ongoing share‑repurchase program signals confidence that Berkshire’s stock is undervalued relative to its book, while the recent strategic acquisitions suggest a willingness to diversify into complementary areas like insurance (Tokio Marine) and specialty chemicals (OxyChem). If Abel can balance these moves—maintaining a tight core while judiciously expanding into adjacent sectors—Berkshire could set a new template for how cash‑rich conglomerates navigate the post‑pandemic investment landscape, where capital efficiency and strategic focus are increasingly prized.